Lipids and oocyte developmental competence: the role of fatty acids and β-oxidation
Metabolism and ATP levels within the oocyte and adjacent cumulus cells are associated
with quality of oocyte and optimal development of a healthy embryo. Lipid metabolism …
with quality of oocyte and optimal development of a healthy embryo. Lipid metabolism …
Nuclear receptors: recent drug discovery for cancer therapies
L Zhao, S Zhou, JÅ Gustafsson - Endocrine reviews, 2019 - academic.oup.com
Nuclear receptors (NRs) are transcription factors actively involved in many aspects of human
physiology and pathology, serving as sensors of stimuli, master regulators of downstream …
physiology and pathology, serving as sensors of stimuli, master regulators of downstream …
Transcription factors in cancer development and therapy
Cancer is a multi-step process and requires constitutive expression/activation of
transcription factors (TFs) for growth and survival. Many of the TFs reported so far are critical …
transcription factors (TFs) for growth and survival. Many of the TFs reported so far are critical …
[HTML][HTML] Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety
P Bouchard, N Chabbert-Buffet, BCJM Fauser - Fertility and sterility, 2011 - Elsevier
OBJECTIVE: To discuss the mechanism of action of selective progesterone receptor
modulators (SPRMs) and summarize the preclinical and clinical efficacy and safety data …
modulators (SPRMs) and summarize the preclinical and clinical efficacy and safety data …
Antiprogestins in breast cancer treatment: are we ready?
CLM Lanari, V Wargon, PA Rojas, A Molinolo - 2012 - ri.conicet.gov.ar
Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer
death in females worldwide. It is accepted that breast cancer is not a single disease, but …
death in females worldwide. It is accepted that breast cancer is not a single disease, but …
Treatment of advanced uterine leiomyosarcoma with aromatase inhibitors
R O'Cearbhaill, Q Zhou, A Iasonos, RA Soslow… - Gynecologic …, 2010 - Elsevier
BACKGROUND: Aromatase inhibitors are sometimes used in the treatment of selected
patients with uterine leiomyosarcoma (LMS), but there are few data assessing the efficacy of …
patients with uterine leiomyosarcoma (LMS), but there are few data assessing the efficacy of …
DNA damage responses in mammalian oocytes
JK Collins, KT Jones - Reproduction, 2016 - rep.bioscientifica.com
Antiprogestins constitute a group of compounds, developed since the early 1980s, that bind
progesterone receptors with different affinities. The first clinical uses for antiprogestins were …
progesterone receptors with different affinities. The first clinical uses for antiprogestins were …
Antiprogestin mifepristone inhibits the growth of cancer cells of reproductive and non-reproductive origin regardless of progesterone receptor expression
CR Tieszen, AA Goyeneche, BAN Brandhagen… - BMC cancer, 2011 - Springer
Background Mifepristone (MF) has been largely used in reproductive medicine due to its
capacity to modulate the progesterone receptor (PR). The study of MF has been expanded …
capacity to modulate the progesterone receptor (PR). The study of MF has been expanded …
Antiprogestins in gynecological diseases
AA Goyeneche, CM Telleria - Reproduction (Cambridge …, 2015 - rep.bioscientifica.com
Antiprogestins constitute a group of compounds, developed since the early 1980s, that bind
progesterone receptors with different affinities. The first clinical uses for antiprogestins were …
progesterone receptors with different affinities. The first clinical uses for antiprogestins were …
Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc
JS Podolski - US Patent 8,735,381, 2014 - Google Patents
The present invention relates to methods of administering compositions comprising a
progesterone receptor antagonist for use in treating estrogen-dependent conditions. The …
progesterone receptor antagonist for use in treating estrogen-dependent conditions. The …